Financial Daily from THE HINDU group of publications
Tuesday, Dec 20, 2005
Financial Daily from THE HINDU group of publications Tuesday, Dec 20, 2005 |
|
|
|
|
|
|
|
Corporate
-
Announcements Aurobindo gets 6 ARVs WHO pre-qualified Our Bureau
Hyderabad , Dec. 19 AUROBINDO Pharma Ltd (APL) has got six more of its ARV (anti retro viral) products onto the World Health Organisation (WHO) pre-qualification list. The products included are: Efavirenz tablets - 600 mg; Lamivudine oral solution - 10 mg/ml; Lamivudine and Zidovudine tablets - 150/300 mg; Stavudine capsules - 30 mg; Stavudine capsules - 40 mg; and Zidovudine oral solution - 50 mg/5 ml. Following this inclusion, the total number of the company's ARV products on WHO's pre-qualification list has gone up to 10, according to a press release from the company here today. The products included previously are Zidovudine tablets 300 mg, Lamivudine tablets 150 mg, Lamivudine tablets 300 mg and Nevirapine tablets 200 mg. tablets. This is the first time that Efavirenz tablets, an important first-line agent in the treatment of HIV/AIDS, are appearing on the WHO pre-qualification list.
More Stories on : Announcements
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2005, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|